Related Experiment Video
Updated: Nov 1, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Hospital acquired pneumonia risk factors in children with Acute Lymphoblastic Leukemia on chemotherapy
Anitha Marllyin Mairuhu1, Mia Ratwita Andarsini1, Retno Asih Setyoningrum1
1Department of Child Health, Universitas Airlangga, Faculty of Medicine Dr. Soetomo General Academic Hospital, Surabaya Indonesia.
Insights
Hospital-Acquired Pneumonia (HAP) is a significant risk for children with Acute Lymphoblastic Leukemia (ALL) undergoing chemotherapy. Risk stratification, chemotherapy phase, and neutropenia are key factors influencing HAP incidence in this vulnerable population.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Hematology
Background:
- Infection is a leading cause of morbidity and mortality in pediatric Acute Lymphoblastic Leukemia (ALL) patients on chemotherapy.
- Hospital-Acquired Pneumonia (HAP) represents a significant threat requiring early intervention for at-risk children with ALL.
Purpose of the Study:
- To identify and analyze risk factors associated with the incidence of Hospital-Acquired Pneumonia (HAP) in pediatric patients undergoing chemotherapy for Acute Lymphoblastic Leukemia (ALL).
Main Methods:
- An observational case-control study was conducted involving pediatric ALL patients on chemotherapy between 2016 and 2018.
- Cases were patients with HAP, and controls were patients without HAP.
- Nine potential risk factors were analyzed using bivariate and multivariate statistical methods, including logistic regression.
Main Results:
- The study included 120 children.
- Significant risk factors for HAP in pediatric ALL patients on chemotherapy were identified as risk stratification (p = 0.009), chemotherapy phase (p < 0.001), and neutropenia (p < 0.001).
- Age, gender, nutritional status, length of stay, anemia, and thrombocytopenia were not found to be significant risk factors.
Conclusions:
- Risk stratification, chemotherapy phase, and neutropenia are significantly associated with the incidence of Hospital-Acquired Pneumonia (HAP) in children with Acute Lymphoblastic Leukemia (ALL) undergoing chemotherapy.
Background:
Over the past 10 years, infection has remained as the main cause of illness and mortality among children with Acute Lymphoblastic Leukemia on chemotherapy. The high incidence of Hospital-Acquired Pneumonia in children with Acute Lymphoblastic Leukemia on chemotherapy with risk factors should be intervened earlier.
Methods:
An observational case control study of children with Acute Lymphoblastic Leukemia on chemotherapy. Patient with Hospital-Acquired Pneumonia considered as case and patient without Hospital-Acquired Pneumonia as control to analyze risk factors that affect the incidence of Hospital-Acquired Pneumonia in children with Acute Lymphoblastic Leukemia on chemotherapy from 2016 to 2018 was performed in the pediatric ward Dr. Soetomo General Academic Hospital with a total sampling technique. Nine risk factors were analyzed: age, gender, nutritional status, length of stay, risk stratification, chemotherapy phase, anemia, neutropenia, and thrombocytopenia. Bivariate and multivariate analysis using chi-square, continuity correction, and logistic regression was used for statistical analysis.
Results:
120 children enrolled the study. Analyzed of risk factors showed risk stratification (p = 0.009), chemotherapy phase (p < 0.001), and neutropenia (p < 0.001) was proven to significantly affect the incidence of Hospital-Acquired Pneumonia in children with Acute Lymphoblastic Leukemia on chemotherapy. Age, gender, nutritional status, length of stay, anemia, and thrombocytopenia were not proven to be a risk factor that affects the incidence of Hospital-Acquired Pneumonia in children with Acute Lymphoblastic Leukemia on chemotherapy.
Conclusion:
The incidence of Hospital-Acquired Pneumonia in children with Acute Lymphoblastic Leukemia on chemotherapy is significantly affected by the risk stratification, chemotherapy phase, and neutropenia.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia II: Pathophysiology
Pharmacokinetics in Pediatric Patients: Drug Excretion

